Cost-Effectiveness Analysis of Gemtuzumab Ozogamicin for First-Line Treatment of Patients with Cd-33 Positive Acute Myeloid Leukaemia in Spain [Corrigendum]

ClinicoEconomics and Outcomes Research ◽

10.2147/ceor.s328284 ◽

2021 ◽

Vol Volume 13 ◽

pp. 645-646

Author(s):

Maria Mareque ◽

Pau Montesinos ◽

Patricia Font ◽

José María Guinea ◽

Adolfo de la Fuente ◽

...

Keyword(s):

Cost Effectiveness ◽

Acute Myeloid Leukaemia ◽

Myeloid Leukaemia ◽

Gemtuzumab Ozogamicin ◽

Cost Effectiveness Analysis ◽

Line Treatment ◽

First Line ◽

Effectiveness Analysis ◽

First Line Treatment ◽

Acute Myeloid

Download Full-text

Cost-Effectiveness Analysis of Gemtuzumab Ozogamicin for First-Line Treatment of Patients with Cd-33 Positive Acute Myeloid Leukaemia in Spain

ClinicoEconomics and Outcomes Research ◽

10.2147/ceor.s302097 ◽

2021 ◽

Vol Volume 13 ◽

pp. 263-277

Author(s):

Maria Mareque ◽

Pau Montesinos ◽

Patricia Font ◽

José María Guinea ◽

Adolfo de la Fuente ◽

...

Keyword(s):

Cost Effectiveness ◽

Acute Myeloid Leukaemia ◽

Myeloid Leukaemia ◽

Gemtuzumab Ozogamicin ◽

Cost Effectiveness Analysis ◽

Line Treatment ◽

First Line ◽

Effectiveness Analysis ◽

First Line Treatment ◽

Acute Myeloid

Download Full-text

Cost Effectiveness of Gemtuzumab Ozogamicin in the First-Line Treatment of Acute Myeloid Leukaemia in the UK

PharmacoEconomics - Open ◽

10.1007/s41669-021-00278-3 ◽

2021 ◽

Author(s):

T. Alexander Russell-Smith ◽

James Brockbank ◽

Carla Mamolo ◽

Christopher Knight

Keyword(s):

Cost Effectiveness ◽

Acute Myeloid Leukaemia ◽

Myeloid Leukaemia ◽

Gemtuzumab Ozogamicin ◽

Line Treatment ◽

First Line ◽

The Uk ◽

First Line Treatment ◽

Acute Myeloid

Download Full-text

PCN264 Cost-Effectiveness Analysis of Gemtuzumab Ozogamicin in Combination with Daunorubicin and Cytarabine for the Treatment of Acute Myeloid Leukaemia in Portugal

Value in Health ◽

10.1016/j.jval.2020.08.401 ◽

2020 ◽

Vol 23 ◽

pp. S469-S470

Author(s):

A.T. Paquete ◽

M. Inês ◽

M. Borges ◽

L. Silva Miguel

Keyword(s):

Cost Effectiveness ◽

Acute Myeloid Leukaemia ◽

Myeloid Leukaemia ◽

Gemtuzumab Ozogamicin ◽

Cost Effectiveness Analysis ◽

Effectiveness Analysis ◽

Acute Myeloid

Download Full-text

Author response for "REAL‐WORD EXPERIENCE WITH DECITABINE AS A FIRST‐LINE TREATMENT IN 306 ELDERLY ACUTE MYELOID LEUKAEMIA PATIENTS UNFIT FOR INTENSIVE CHEMOTHERAPY"

10.1002/hon.2663/v2/response1 ◽

2019 ◽

Author(s):

Monica Bocchia ◽

Anna Candoni ◽

Erika Borlenghi ◽

Marzia Defina ◽

Carla Filì ◽

...

Keyword(s):

Acute Myeloid Leukaemia ◽

Myeloid Leukaemia ◽

Author Response ◽

Intensive Chemotherapy ◽

Line Treatment ◽

Real Word ◽

First Line ◽

First Line Treatment ◽

Acute Myeloid

Download Full-text

Cost-Effectiveness Analysis Of Panitumumab + Folfox Compared To Cetuximab + Folfiri As First-Line Treatment For Patients With Wild-Type (Wt) Ras (Exons 2, 3, And 4 Of Kras And Nras) Metastatic Colorectal Cancer (Mcrc) In Colombia

Value in Health ◽

10.1016/j.jval.2015.09.1188 ◽

2015 ◽

Vol 18 (7) ◽

pp. A460 ◽

Cited By ~ 2

Author(s):

J Vargas-Valencia ◽

J Garcia Perlaza

Keyword(s):

Colorectal Cancer ◽

Cost Effectiveness ◽

Metastatic Colorectal Cancer ◽

Cost Effectiveness Analysis ◽

Line Treatment ◽

Wild Type ◽

First Line ◽

Effectiveness Analysis ◽

First Line Treatment

Download Full-text

Cost-effectiveness analysis in the Spanish setting of the PEAK trial of panitumumab plus mFOLFOX6 compared with bevacizumab plus mFOLFOX6 for first-line treatment of patients with wild-type RAS metastatic colorectal cancer

Journal of Medical Economics ◽

10.1080/13696998.2017.1285780 ◽

2017 ◽

Vol 20 (6) ◽

pp. 574-584 ◽

Cited By ~ 3

Author(s):

Fernando Rivera ◽

Manuel Valladares ◽

Salvador Gea ◽

Noemí López-Martínez

Keyword(s):

Colorectal Cancer ◽

Cost Effectiveness ◽

Metastatic Colorectal Cancer ◽

Cost Effectiveness Analysis ◽

Line Treatment ◽

Wild Type ◽

First Line ◽

Effectiveness Analysis ◽

First Line Treatment

Download Full-text

Cost-Effectiveness Analysis Comparing FOLFIRINOX and Nab-Paclitaxel (Abaraxane) Plus Gemcitabine For First-Line Treatment Of Patients with Metastatic Pancreatic Cancer from the US Societal Perspective

Value in Health ◽

10.1016/j.jval.2016.03.1607 ◽

2016 ◽

Vol 19 (3) ◽

pp. A153

Author(s):

W Cheng ◽

JW Hay

Keyword(s):

Pancreatic Cancer ◽

Cost Effectiveness ◽

Societal Perspective ◽

Cost Effectiveness Analysis ◽

Metastatic Pancreatic Cancer ◽

Line Treatment ◽

First Line ◽

Effectiveness Analysis ◽

The Us ◽

First Line Treatment

Download Full-text

Commentary on: A cost-effectiveness analysis of onabotulinumtoxin A as first-line treatment for overactive bladder

International Urogynecology Journal ◽

10.1007/s00192-018-3662-y ◽

2018 ◽

Vol 29 (8) ◽

pp. 1221-1221

Author(s):

Abdelmageed Abdelrahman

Keyword(s):

Cost Effectiveness ◽

Overactive Bladder ◽

Cost Effectiveness Analysis ◽

Line Treatment ◽

First Line ◽

Effectiveness Analysis ◽

Onabotulinumtoxin A ◽

First Line Treatment

Download Full-text

Cost-effectiveness analysis of pembrolizumab compared to standard of care as first line treatment for patients with advanced melanoma in Hong Kong

Cost Effectiveness and Resource Allocation ◽

10.1186/s12962-020-0200-9 ◽

2020 ◽

Vol 18 (1) ◽

Cited By ~ 1

Author(s):

Herbert H. Loong ◽

Carlos K. H. Wong ◽

Linda K. S. Leung ◽

S. C. Tan ◽

Jason Jen ◽

...

Keyword(s):

Hong Kong ◽

Cost Effectiveness ◽

Standard Of Care ◽

Cost Effectiveness Analysis ◽

Advanced Melanoma ◽

Line Treatment ◽

First Line ◽

Effectiveness Analysis ◽

First Line Treatment

Download Full-text

Cost-effectiveness analysis of gemcitabine plus cisplatin versus fluorouracil plus cisplatin for first-line treatment of recurrent or metastatic nasopharyngeal carcinoma

Oral Oncology ◽

10.1016/j.oraloncology.2019.04.022 ◽

2019 ◽

Vol 94 ◽

pp. 80-85 ◽

Cited By ~ 6

Author(s):

Xudong Chen ◽

Weiting Liang ◽

Ning Wan ◽

Li Zhang ◽

Yunpeng Yang ◽

...

Keyword(s):

Cost Effectiveness ◽

Nasopharyngeal Carcinoma ◽

Cost Effectiveness Analysis ◽

Line Treatment ◽

First Line ◽

Effectiveness Analysis ◽

Metastatic Nasopharyngeal Carcinoma ◽

First Line Treatment

Download Full-text